Kabra Drugs Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 31.96 | 46.29 | 35.52 |
| Operating Expense | 29.36 | 43.43 | 34.07 |
| Net Profit | 1.92 | 2.12 | 1.06 |
| Net Profit Margin | 6.01% | 4.58% | 2.98% |
| Earning Per Share | 0.81 | 0.90 | 0.45 |
| EBIDTA | 2.59 | 2.87 | 1.45 |
| Effective Tax Rate | 25.10% | 25.09% | 24.83% |
Particulars
Sep 2026
Revenue31.96
Operating Expense29.36
Net Profit1.92
Net Profit Margin6.01
Earning Per Share0.81
EBIDTA2.59
Effective Tax Rate25.10
